Revvity, Inc. (RVTY)
100.33
+0.42
(+0.42%)
USD |
NYSE |
Feb 20, 16:00
100.35
+0.02
(+0.02%)
Pre-Market: 20:00
Revvity Research and Development Expense (Quarterly) : 58.18M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 117.00M |
| Bruker Corp. | 99.60M |
| Avantor, Inc. | -- |
| Bio-Rad Laboratories, Inc. | 66.00M |
| Azenta, Inc. | 9.189M |